These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18216472)

  • 21. Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat.
    Nurmio M; Toppari J; Zaman F; Andersson AM; Paranko J; Söder O; Jahnukainen K
    Int J Androl; 2007 Aug; 30(4):366-76; discussion 376. PubMed ID: 17705809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of Wenyang Huazhuo Tongluo recipe contained serum on proliferation and cell cycle of systemic sclerosis skin fibroblasts].
    Bian H; Fan YS; Lou LH; Mao BY; Shi JY
    Zhong Yao Cai; 2009 Jun; 32(6):936-9. PubMed ID: 19764335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis.
    Bibi Y; Gottlieb AB
    J Am Acad Dermatol; 2008 Oct; 59(4):654-8. PubMed ID: 18571768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.
    Magro L; Catteau B; Coiteux V; Bruno B; Jouet JP; Yakoub-Agha I
    Bone Marrow Transplant; 2008 Dec; 42(11):757-60. PubMed ID: 18762765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.
    Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M
    Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imatinib mesylate treatment of nephrogenic systemic fibrosis.
    Kay J; High WA
    Arthritis Rheum; 2008 Aug; 58(8):2543-8. PubMed ID: 18668587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.
    Fraticelli P; De Vita S; Franzolini N; Svegliati S; Scott CA; Tonnini C; Spadoni T; Gabrielli B; Pomponio G; Moroncini G; Gabrielli A
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S160-7. PubMed ID: 26339895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new therapeutic avenue for severe systemic sclerosis: imatinib mesylate].
    Taïeb A; Constans J; Mahon FX
    Rev Med Interne; 2008 Mar; 29(3):173-5. PubMed ID: 17597261
    [No Abstract]   [Full Text] [Related]  

  • 29. Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts.
    Gioni V; Karampinas T; Voutsinas G; Roussidis AE; Papadopoulos S; Karamanos NK; Kletsas D
    Mol Cancer Res; 2008 May; 6(5):706-14. PubMed ID: 18505916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Imatinib and solid tumours].
    Arifi S; El Sayadi H; Dufresne A; Ray-Coquard I; Fayette J; Méeus P; Ranchère D; Decouvelaere AV; Alberti L; Tabone-Eglinger S; Blay JY; Cassier P
    Bull Cancer; 2008 Jan; 95(1):99-106. PubMed ID: 18230575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
    Feghali CA; Boulware DW; Levy LS
    J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors.
    Ioannou M; Demertzis N; Iakovidou I; Kottakis S
    Anticancer Res; 2007; 27(2):1143-7. PubMed ID: 17465254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired growth response to endothelin-1 in scleroderma fibroblasts.
    Kikuchi K; Kadono T; Sato S; Tamaki K; Takehara K
    Biochem Biophys Res Commun; 1995 Feb; 207(2):829-38. PubMed ID: 7864878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.
    Akhmetshina A; Dees C; Pileckyte M; Szucs G; Spriewald BM; Zwerina J; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2008 Aug; 58(8):2553-64. PubMed ID: 18668558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of imatinib mesylate effects on glioblastoma aggressiveness with SPECT radiotracer 99mTc-(v)-DMSA.
    Le Jeune N; Dubois F; Bin V; Perek N
    Eur J Cancer; 2006 May; 42(8):1004-13. PubMed ID: 16564690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.
    Karvinen H; Rutanen J; Leppänen O; Lach R; Levonen AL; Eriksson U; Ylä-Herttuala S
    Eur J Clin Invest; 2009 Apr; 39(4):320-7. PubMed ID: 19292888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sera from patients with scleroderma inhibit fibroblast micromotions monitored electrically.
    Huang CN; Lo CM; Hsu TC; Tsay GJ
    J Rheumatol; 1999 Jun; 26(6):1312-7. PubMed ID: 10381049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testis.
    Nurmio M; Kallio J; Toppari J; Jahnukainen K
    Reprod Toxicol; 2008 Aug; 25(4):442-6. PubMed ID: 18472395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
    Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
    Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas.
    Orzan F; Terreni MR; Longoni M; Boari N; Mortini P; Doglioni C; Riva P
    Oncol Rep; 2007 Jul; 18(1):249-52. PubMed ID: 17549375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.